What Makes a Healthcare Startup Attractive to VCs and Private Equity?
Biotech, Healthcare, Investment Curtis Wadsworth Biotech, Healthcare, Investment Curtis Wadsworth

What Makes a Healthcare Startup Attractive to VCs and Private Equity?

So far in 2025, Pittsburgh-based healthcare startup Abridge has landed $250 million in funding, UK-based OrganOx closed $142 million, and Transcarent merged with Accolade, Inc.. Both Transcarent and Datavant appear to be open to additional acquisitions as they build toward IPO. Meanwhile, healthcare investors and several healthcare mega-companies have signaled that they "don't much of an appetite" for big deals this year according to Business Insider.

What does this mean? Let's figure this out!

Read More
Doomed to Fail: The Limits of Musk’s Case Against the WFA
Antitrust, Glitches and Gains Curtis Wadsworth Antitrust, Glitches and Gains Curtis Wadsworth

Doomed to Fail: The Limits of Musk’s Case Against the WFA

X Corp. (formally “Twitter”) has sued the World Federation of Advertisers (WFA) and a number of member companies for orchestrating an illegal boycott of Twitter. X Corp. v. World Federation of Advertisers. The complaint asserts that it is “an antitrust action relating to a group boycott by competing advertisers of one of the most popular social media platforms in the United States.”  The lawsuit premise of this (forcing advertisers to do business with a floundering company using antitrust law) is absurd, and should not survive summary judgment (initial motions).  

Read More